LanZhou Foci Pharmaceutical Co.,Ltd.

002644

CNE1000019W4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-25 EDT			5-day change	1st Jan Change
6.6 ^CNY	+2.96%		-3.08%	-32.31%

06-18	LanZhou Foci Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan on A Shares for the Year 2023, Payable on 25 June 2024	CI
05-06	Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for the Year 2023	CI

Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for the Year 2023

May 06, 2024 at 03:32 pm

LanZhou Foci Pharmaceutical Co.,Ltd. at its AGM held on April 30, 2024, approved 2023 profit distribution plan as follows: Cash dividend/10 shares (tax included): CNY 0.30000000.

Latest news about LanZhou Foci Pharmaceutical Co.,Ltd.

LanZhou Foci Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan on A Shares for the Year 2023, Payable on 25 June 2024	06-18	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for the Year 2023	05-06	CI
Lanzhou Foci Pharmaceutical Chairman Resigns	04-10	MT
Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	04-09	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-09	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-09	CI
Lanzhou Foci Pharma to Buy 60% Stake in Local Peer for 15.5 Million Yuan	12-26	MT
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Gansu Provincial State-owned Asset Investment Group Co.,Ltd completed the acquisition of 0.80% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 39 million.	23-10-22	CI
LanZhou Foci Pharmaceutical Co.,Ltd.(XSEC:002644) added to S&P Global BMI Index	23-09-18	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-02	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 15, 2023	23-06-07	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2022	23-04-21	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Announces Final Cash Dividend (Tax Included) for 2022	23-03-31	CI
Gansu Provincial State-owned Asset Investment Group Co.,Ltd made a tender off to acquire a 38.37% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 1.8 billion.	23-02-27	CI
Lanzhou Foci Pharma Appoints CFO	22-12-01	MT
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022	22-05-20	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for 2021	22-03-16	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-15	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-19	CI

Chart LanZhou Foci Pharmaceutical Co.,Ltd.

Duration

Period

Chart LanZhou Foci Pharmaceutical Co.,Ltd.

More charts

LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Companyâs main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-07-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
LANZHOU FOCI PHARMACEUTICAL CO.,LTD.	-32.31%	464M
DONG-E-E-JIAO CO.,LTD.	+29.99%	5.68B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.99%	3.61B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.59%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.15%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.23%	2.33B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.55%	1.89B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+44.37%	1.49B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-11.29%	1.46B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+42.86%	1.37B